The National COVID-19 Clinical Evidence Taskforce will receive $1.5 million from the Medical Research Future Fund (MRFF) to deliver ‘living guidelines’ on the clinical management of patients with suspected or confirmed COVID-19 infection across primary, acute and critical care settings.
